Real-time measurement of anti-HBs level and donor-specific transfusion via portal vein may reduce amount of HBIG after living related liver transplantation.
Sato
Yoshinobu
Y
Ichida
Takafumi
T
Hatakeyama
Katsuyoshi
K
D006084:Graft Rejection / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000032:analysis / Q000187:drug effects*; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D019259:Lamivudine / Q000008:administration & dosage*; D016031:Liver Transplantation / Q000276:immunology*; D019520:Living Donors; D011169:Portal Vein; D011300:Preoperative Care; D012680:Sensitivity and Specificity; D014181:Transplantation Immunology; D016896:Treatment Outcome
D006514:Hepatitis B Surface Antigens; D007136:Immunoglobulins; D019259:Lamivudine; C045213:hepatitis B hyperimmune globulin